Abivax (ABVX) DMA 100 (2024 - 2026)
Abivax (ABVX) DMA 100 (2024 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | DMA 100 |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 3.79 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 163.02 |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.54 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 21.83 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 8.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 3.85 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 3.98 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 452.54 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 117.62 |
| 10 | Regeneron Pharmaceuticals | 63.60 Bn | 54.85 Bn | 3.31 Bn | 733.99 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 8, 2026 | 117.62 |
| Jun 5, 2026 | 117.80 |
| Jun 4, 2026 | 117.97 |
| Jun 3, 2026 | 118.06 |
| Jun 2, 2026 | 118.32 |
| Jun 1, 2026 | 118.85 |
| May 29, 2026 | 118.74 |
| May 28, 2026 | 118.65 |
| May 27, 2026 | 118.69 |
| May 26, 2026 | 118.74 |
| May 22, 2026 | 118.86 |
| May 21, 2026 | 119.04 |
| May 20, 2026 | 119.23 |
| May 19, 2026 | 119.48 |
| May 18, 2026 | 119.72 |
| May 15, 2026 | 119.97 |
| May 14, 2026 | 119.97 |
| May 13, 2026 | 119.90 |
| May 12, 2026 | 119.79 |
| May 11, 2026 | 119.69 |